[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]
- PMID: 32916743
- DOI: 10.1055/a-1165-6994
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]
Conflict of interest statement
Reinhold Kreutz hat Honorare für Vortragstätigkeit, Beratertätigkeit oder Unterstützung für Forschung erhalten von Bayer Pharma, Berlin-Chemie Menarini, Daiichi Sankyo, Ferrer, Sanofi, Servier außerhalb der aktuellen Arbeit.
Similar articles
-
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].Dtsch Med Wochenschr. 2020 May;145(10):682-686. doi: 10.1055/a-1152-3469. Epub 2020 Apr 22. Dtsch Med Wochenschr. 2020. PMID: 32323279 Free PMC article. Review. German.
-
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25. Hypertension. 2020. PMID: 32208987 Free PMC article.
-
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4. Pharmacol Res. 2020. PMID: 32505834 Free PMC article. No abstract available.
-
[Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?].Rev Med Suisse. 2020 May 13;16(693):1003-1007. Rev Med Suisse. 2020. PMID: 32401442 French.
-
The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.Cells. 2020 Jul 16;9(7):1704. doi: 10.3390/cells9071704. Cells. 2020. PMID: 32708755 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources